Onychomycosis Market Research Report Information By Type (Distal Subungual Onychomycosis (DSO), White Superficial Onychomycosis (WSO), Proximal Subungual Onychomycosis (PSO), Candida Onychomycosis, Others), By Treatment Type (Drug Treatment, Topical Therapy and Others), By End Users (Hospital Pharmacies, Retail Pharmacies, And Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032

1 Executive Summary

1.1 Market Attractiveness Analysis 16

2 Market Introduction

2.1 Definition 19

2.2 Scope Of The Study 19

2.3 Assumptions 19

2.4 Market Structure 20

3 Research Methodology

3.1 Research Process 21

3.2 Data Mining 21

3.3 Secondary Research 22

3.4 Primary Research 23

3.5 Forecasting Techniques 25

3.6 Research Methodology For Market Size Estimation 27

3.6.1 Bottom-Up Approach 27

3.6.2 Top-Down Approach 28

3.6.3 Data Triangulation 29

3.6.4 Validation 29

4 Market Dynamics

4.1 Overview 30

4.2 Drivers 31

4.2.1 Worldwide Rising Prevalence Of Onychomycosis 31

4.2.2 Rising Per Capita Healthcare Expenditure 31

4.2.3 Surging Diabetic Patient Population 31

4.2.4 Increasing Prevalence Of Peripheral Artery Disease (PAD) 31

4.3 Restraints 32

4.3.1 Lack Of Awareness About Onychomycosis 32

4.3.2 Side-Effects Associated With Onychomycosis Treatment Drugs 32

4.4 Opportunity 33

4.4.1 Increase In The Number Of Pipeline Products 33

5 Market Factor Analysis

5.1 Porter’s Five Forces Model 34

5.1.1 Bargaining Power Of Suppliers 34

5.1.2 Bargaining Power Of Buyers 34

5.1.3 Threat Of New Entrants 35

5.1.4 Threat Of Substitutes 35

5.1.5 Intensity Of Rivalry 35

5.2 Value Chain Analysis 36

5.2.1 R&D 36

5.2.2 Manufacturing 36

5.2.3 Distribution 36

5.2.4 Marketing & Sales 36

5.2.5 Post-Sales Monitoring 37

6 Onychomycosis Market, By Type

6.1 Overview 38

6.2 Distal Subungual Onychomycosis 40

6.3 White Superficial Onychomycosis 41

6.4 Candida Onychomycosis 42

6.5 Proximal Subungual Onychomycosis 43

6.6 Others 43

7 Onychomycosis Market, By Treatment Type

7.1 Overview 44

7.2 Drug Treatment 45

7.3 Topical Therapy 46

7.4 Others 46

8 Onychomycosis Market, By Distribution Channel

8.1 Overview 47

8.2 Hospital Pharmacies 48

8.3 Retail Pharmacies 49

8.4 Others 49

9 Global Onychomycosis Market, By Region

9.1 Overview 50

9.2 Americas 52

Onychomycosis Market, By Type

Onychomycosis Market, By Treatment Type

Onychomycosis Market, By Distribution Channel

9.2.1 North America 55

Onychomycosis Market, By Type

Onychomycosis Market, By Treatment Type

Onychomycosis Market, By Distribution Channel

9.2.1.1 US 57

Onychomycosis Market, By Type

Onychomycosis Market, By Treatment Type

Onychomycosis Market, By Distribution Channel

9.2.1.2 Canada 59

Onychomycosis Market, By Type

Onychomycosis Market, By Treatment Type

Onychomycosis Market, By Distribution Channel

9.2.2 Latin America 60

Onychomycosis Market, By Type

Onychomycosis Market, By Treatment Type

Onychomycosis Market, By Distribution Channel

9.3 Asia-Pacific 62

Onychomycosis Market, By Type

Onychomycosis Market, By Treatment Type

Onychomycosis Market, By Distribution Channel

9.3.1 Japan 65

Onychomycosis Market, By Type

Onychomycosis Market, By Treatment Type

Onychomycosis Market, By Distribution Channel

9.3.2 Australia 66

Onychomycosis Market, By Type

Onychomycosis Market, By Treatment Type

Onychomycosis Market, By Distribution Channel

9.3.3 China 68

Onychomycosis Market, By Type

Onychomycosis Market, By Treatment Type

Onychomycosis Market, By Distribution Channel

9.3.4 India 69

Onychomycosis Market, By Type

Onychomycosis Market, By Treatment Type

Onychomycosis Market, By Distribution Channel

9.3.5 South Korea 71

Onychomycosis Market, By Type

Onychomycosis Market, By Treatment Type

Onychomycosis Market, By Distribution Channel

9.3.6 Rest Of Asia-Pacific 72

Onychomycosis Market, By Type

Onychomycosis Market, By Treatment Type

Onychomycosis Market, By Distribution Channel

9.4 Europe 74

Onychomycosis Market, By Type

Onychomycosis Market, By Treatment Type

Onychomycosis Market, By Distribution Channel

9.4.1 Western Europe 77

Onychomycosis Market, By Type

Onychomycosis Market, By Treatment Type

Onychomycosis Market, By Distribution Channel

9.4.1.1 Germany 79

Onychomycosis Market, By Type

Onychomycosis Market, By Treatment Type

Onychomycosis Market, By Distribution Channel

9.4.1.2 France 81

Onychomycosis Market, By Type

Onychomycosis Market, By Treatment Type

Onychomycosis Market, By Distribution Channel

9.4.1.3 UK 82

Onychomycosis Market, By Type

Onychomycosis Market, By Treatment Type

Onychomycosis Market, By Distribution Channel

9.4.1.4 Italy 84

Onychomycosis Market, By Type

Onychomycosis Market, By Treatment Type

Onychomycosis Market, By Distribution Channel

9.4.1.5 Spain 85

Onychomycosis Market, By Type

Onychomycosis Market, By Treatment Type

Onychomycosis Market, By Distribution Channel

9.4.1.6 Rest Of Western Europe 87

Onychomycosis Market, By Type

Onychomycosis Market, By Treatment Type

Onychomycosis Market, By Distribution Channel

9.4.2 Eastern Europe 88

Onychomycosis Market, By Type

Onychomycosis Market, By Treatment Type

Onychomycosis Market, By Distribution Channel

9.5 Middle East & Africa 90

Onychomycosis Market, By Type

Onychomycosis Market, By Treatment Type

Onychomycosis Market, By Distribution Channel

9.5.1 Middle East 92

Onychomycosis Market, By Type

Onychomycosis Market, By Treatment Type

Onychomycosis Market, By Distribution Channel

9.5.2 Africa 94

Onychomycosis Market, By Type

Onychomycosis Market, By Treatment Type

Onychomycosis Market, By Distribution Channel

10 Competitive Landscape

10.1 Overview 96

11 Company Profile

11.1 Bausch Health Companies, Inc. 98

11.1.1 Company Overview 98

11.1.2 Financial Overview 98

11.1.3 Products/Services Offered 99

11.1.4 Key Developments 99

11.1.5 SWOT Analysis 99

11.1.6 Key Strategies 99

11.2 Dr. Reddy’s Laboratories Ltd 100

11.2.1 Company Overview 100

11.2.2 Financial Overview 100

11.2.3 Products/Services Offered 101

11.2.4 Key Developments 101

11.2.5 SWOT Analysis 101

11.2.6 Key Strategies 101

11.3 Galderma Laboratories 102

11.3.1 Company Overview 102

11.3.2 Financial Overview 102

11.3.3 Products/Services Offered 103

11.3.4 Key Developments 103

11.3.5 SWOT Analysis 103

11.3.6 Key Strategies 103

11.4 GlaxoSmithKline PLC 104

11.4.1 Company Overview 104

11.4.2 Financial Overview 104

11.4.3 Products/Services Offered 105

11.4.4 Key Developments 105

11.4.5 SWOT Analysis 105

11.4.6 Key Strategies 105

11.5 Johnson & Johnson Services Inc. 106

11.5.1 Company Overview 106

11.5.2 Financial Overview 106

11.5.3 Products/Services Offered 107

11.5.4 Key Developments 107

11.5.5 SWOT Analysis 107

11.5.6 Key Strategies 107

11.6 Kaken Pharmaceutical Co., Ltd 108

11.6.1 Company Overview 108

11.6.2 Financial Overview 108

11.6.3 Products/Services Offered 108

11.6.4 Key Developments 109

11.6.5 SWOT Analysis 109

11.6.6 Key Strategies 109

11.7 Merz Pharma 110

11.7.1 Company Overview 110

11.7.2 Financial Overview 110

11.7.3 Products/Services Offered 110

11.7.4 Key Developments 110

11.7.5 SWOT Analysis 110

11.7.6 Key Strategies 111

11.8 Moberg Pharma AB 112

11.8.1 Company Overview 112

11.8.2 Financial Overview 112

11.8.3 Products/Services Offered 113

11.8.4 Key Developments 113

11.8.5 SWOT Analysis 113

11.8.6 Key Strategies 113

11.9 Medimetriks Pharmaceuticals, Inc. 114

11.9.1 Company Overview 114

11.9.2 Financial Overview 114

11.9.3 Products/Services Offered 114

11.9.4 Key Developments 114

11.9.5 SWOT Analysis 114

11.9.6 Key Strategy 115

11.10 Novartis AG 116

11.10.1 Company Overview 116

11.10.2 Financial Overview 116

11.10.3 Products/Services Offered 117

11.10.4 Key Developments 117

11.10.5 SWOT Analysis 117

11.10.6 Key Strategies 117

11.11 Pfizer, Inc. 118

11.11.1 Company Overview 118

11.11.2 Financial Overview 118

11.11.3 Products/Services Offered 119

11.11.4 Key Developments 119

11.11.5 SWOT Analysis 119

11.11.6 Key Strategies 119

11.12 Taro Pharmaceuticals Industries Ltd 120

11.12.1 Company Overview 120

11.12.2 Financial Overview 120

11.12.3 Products/Services Offered 121

11.12.4 Key Developments 121

11.12.5 SWOT Analysis 121

11.12.6 Key Strategies 121

12 Appendix

12.1 References 122

12.2 Related Reports 122

13 List Of Tables

TABLE 1 LIST OF ASSUMPTIONS 19

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 24

TABLE 3 ONYCHOMYCOSIS TREATMENT DRUGS PIPELINE 33

TABLE 4 GLOBAL ONYCHOMYCOSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 39

TABLE 5 GLOBAL ONYCHOMYCOSIS MARKET FOR DISTAL SUBUNGUAL ONYCHOMYCOSIS, BY REGION 2023–2030 (USD MILLION) 40

TABLE 6 GLOBAL ONYCHOMYCOSIS MARKET FOR WHITE SUPERFICIAL ONYCHOMYCOSIS, BY REGION 2023–2030 (USD MILLION) 41

TABLE 7 GLOBAL ONYCHOMYCOSIS MARKET FOR CANDIDA ONYCHOMYCOSIS, BY REGION 2023–2030 (USD MILLION) 42

TABLE 8 GLOBAL ONYCHOMYCOSIS MARKET FOR PROXIMAL SUBUNGUAL ONYCHOMYCOSIS, BY REGION 2023–2030 (USD MILLION) 43

TABLE 9 GLOBAL ONYCHOMYCOSIS MARKET, BY TREATMENT TYPE, 2023–2030 (USD MILLION) 45

TABLE 10 GLOBAL ONYCHOMYCOSIS MARKET FOR DRUG TREATMENT, BY REGION 2023–2030 (USD MILLION) 45

TABLE 11 GLOBAL ONYCHOMYCOSIS MARKET FOR TOPICAL THERAPY, BY REGION 2023–2030 (USD MILLION) 46

TABLE 12 GLOBAL ONYCHOMYCOSIS MARKET, BY DISTRIBUTION CHANNEL, 2023–2030, (USD MILLION) 48

TABLE 13 GLOBAL ONYCHOMYCOSIS MARKET FOR HOSPITAL PHARMACIES, BY REGION 2023–2030 (USD MILLION) 48

TABLE 14 GLOBAL ONYCHOMYCOSIS MARKET FOR RETAIL PHARMACIES, BY REGION 2023–2030 (USD MILLION) 49

TABLE 15 GLOBAL ONYCHOMYCOSIS MARKET, BY REGION, 2023–2030 (USD MILLION) 51

TABLE 16 AMERICAS: ONYCHOMYCOSIS MARKET, BY REGION, 2023–2030 (USD MILLION) 53

TABLE 17 AMERICAS: ONYCHOMYCOSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 53

TABLE 18 AMERICAS: ONYCHOMYCOSIS MARKET, BY TREATMENT TYPE, 2023–2030 (USD MILLION) 54

TABLE 19 AMERICAS: ONYCHOMYCOSIS MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION) 54

TABLE 20 NORTH AMERICA: ONYCHOMYCOSIS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 55

TABLE 21 NORTH AMERICA: ONYCHOMYCOSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 56

TABLE 22 NORTH AMERICA: ONYCHOMYCOSIS MARKET, BY TREATMENT TYPE, 2023–2030 (USD MILLION) 56

TABLE 23 NORTH AMERICA: ONYCHOMYCOSIS MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION) 57

TABLE 24 US: ONYCHOMYCOSIS MARKET, BY TYPE, 2023–2030, (USD MILLION) 57

TABLE 25 US: ONYCHOMYCOSIS MARKET, BY TREATMENT TYPE, 2023–2030, (USD MILLION) 58

TABLE 26 US: ONYCHOMYCOSIS MARKET, BY DISTRIBUTION CHANNEL, 2023–2030, (USD MILLION) 58

TABLE 27 CANADA: ONYCHOMYCOSIS MARKET, BY TYPE, 2023–2030, (USD MILLION) 59

TABLE 28 CANADA: ONYCHOMYCOSIS MARKET, BY TREATMENT TYPE, 2023–2030, (USD MILLION) 59

TABLE 29 CANADA: ONYCHOMYCOSIS MARKET, BY DISTRIBUTION CHANNEL, 2023–2030, (USD MILLION) 60

TABLE 30 LATIN AMERICA: ONYCHOMYCOSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 60

TABLE 31 LATIN AMERICA: ONYCHOMYCOSIS MARKET, BY TREATMENT TYPE, 2023–2030 (USD MILLION) 61

TABLE 32 LATIN AMERICA: ONYCHOMYCOSIS MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION) 61

TABLE 33 ASIA-PACIFIC: ONYCHOMYCOSIS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 63

TABLE 34 ASIA-PACIFIC: ONYCHOMYCOSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 63

TABLE 35 ASIA-PACIFIC: ONYCHOMYCOSIS MARKET, BY TREATMENT TYPE, 2023–2030 (USD MILLION) 64

TABLE 36 ASIA-PACIFIC: ONYCHOMYCOSIS MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION) 64

TABLE 37 JAPAN: ONYCHOMYCOSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 65

TABLE 38 JAPAN: ONYCHOMYCOSIS MARKET, BY TREATMENT TYPE, 2023–2030 (USD MILLION) 65

TABLE 39 JAPAN: ONYCHOMYCOSIS MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION) 66

TABLE 40 AUSTRALIA: ONYCHOMYCOSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 66

TABLE 41 AUSTRALIA: ONYCHOMYCOSIS MARKET, BY TREATMENT TYPE, 2023–2030 (USD MILLION) 67

TABLE 42 AUSTRALIA: ONYCHOMYCOSIS MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION) 67

TABLE 43 CHINA: ONYCHOMYCOSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 68

TABLE 44 CHINA: ONYCHOMYCOSIS MARKET, BY TREATMENT TYPE, 2023–2030 (USD MILLION) 68

TABLE 45 CHINA: ONYCHOMYCOSIS MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION) 69

TABLE 46 INDIA: ONYCHOMYCOSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 69

TABLE 47 INDIA: ONYCHOMYCOSIS MARKET, BY TREATMENT TYPE, 2023–2030 (USD MILLION) 70

TABLE 48 INDIA: ONYCHOMYCOSIS MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION) 70

TABLE 49 SOUTH KOREA: ONYCHOMYCOSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 71

TABLE 50 SOUTH KOREA: ONYCHOMYCOSIS MARKET, BY TREATMENT TYPE, 2023–2030 (USD MILLION) 71

TABLE 51 SOUTH KOREA: ONYCHOMYCOSIS MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION) 72

TABLE 52 REST OF ASIA-PACIFIC: ONYCHOMYCOSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 72

TABLE 53 REST OF ASIA-PACIFIC: ONYCHOMYCOSIS MARKET, BY TREATMENT TYPE, 2023–2030 (USD MILLION) 73

TABLE 54 REST OF ASIA-PACIFIC: ONYCHOMYCOSIS MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION) 73

TABLE 55 EUROPE: ONYCHOMYCOSIS MARKET, BY REGION, 2023–2030 (USD MILLION) 75

TABLE 56 EUROPE: ONYCHOMYCOSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 75

TABLE 57 EUROPE: ONYCHOMYCOSIS MARKET, BY TREATMENT TYPE, 2023–2030 (USD MILLION) 76

TABLE 58 EUROPE: ONYCHOMYCOSIS MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION) 76

TABLE 59 WESTERN EUROPE: ONYCHOMYCOSIS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 77

TABLE 60 WESTERN EUROPE: ONYCHOMYCOSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 78

TABLE 61 WESTERN EUROPE: ONYCHOMYCOSIS MARKET, BY TREATMENT TYPE, 2023–2030 (USD MILLION) 78

TABLE 62 WESTERN EUROPE: ONYCHOMYCOSIS MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION) 79

TABLE 63 GERMANY: ONYCHOMYCOSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 79

TABLE 64 GERMANY: ONYCHOMYCOSIS MARKET, BY TREATMENT TYPE, 2023–2030 (USD MILLION) 80

TABLE 65 GERMANY: ONYCHOMYCOSIS MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION) 80

TABLE 66 FRANCE: ONYCHOMYCOSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 81

TABLE 67 FRANCE: ONYCHOMYCOSIS MARKET, BY TREATMENT TYPE, 2023–2030 (USD MILLION) 81

TABLE 68 FRANCE: ONYCHOMYCOSIS MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION) 82

TABLE 69 UK: ONYCHOMYCOSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 82

TABLE 70 UK: ONYCHOMYCOSIS MARKET, BY TREATMENT TYPE, 2023–2030 (USD MILLION) 83

TABLE 71 UK: ONYCHOMYCOSIS MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION) 83

TABLE 72 ITALY: ONYCHOMYCOSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 84

TABLE 73 ITALY: ONYCHOMYCOSIS MARKET, BY TREATMENT TYPE, 2023–2030 (USD MILLION) 84

TABLE 74 ITALY: ONYCHOMYCOSIS MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION) 85

TABLE 75 SPAIN: ONYCHOMYCOSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 85

TABLE 76 SPAIN: ONYCHOMYCOSIS MARKET, BY TREATMENT TYPE, 2023–2030 (USD MILLION) 86

TABLE 77 SPAIN: ONYCHOMYCOSIS MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION) 86

TABLE 78 REST OF WESTERN EUROPE: ONYCHOMYCOSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 87

TABLE 79 REST OF WESTERN EUROPE: ONYCHOMYCOSIS MARKET, BY TREATMENT TYPE, 2023–2030 (USD MILLION) 87

TABLE 80 REST OF WESTERN EUROPE: ONYCHOMYCOSIS MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION) 88

TABLE 81 EASTERN EUROPE: ONYCHOMYCOSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 88

TABLE 82 EASTERN EUROPE: ONYCHOMYCOSIS MARKET, BY TREATMENT TYPE, 2023–2030 (USD MILLION) 89

TABLE 83 EASTERN EUROPE: ONYCHOMYCOSIS MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION) 89

TABLE 84 MIDDLE EAST & AFRICA: ONYCHOMYCOSIS MARKET, BY REGION, 2023 AND 2030 90

TABLE 85 MIDDLE EAST & AFRICA: ONYCHOMYCOSIS MARKET, BY REGION, 2023–2030 (USD MILLION) 90

TABLE 86 MIDDLE EAST & AFRICA: ONYCHOMYCOSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 91

TABLE 87 MIDDLE EAST & AFRICA: ONYCHOMYCOSIS MARKET, BY TREATMENT TYPE, 2023–2030 (USD MILLION) 91

TABLE 88 MIDDLE EAST & AFRICA: ONYCHOMYCOSIS MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION) 92

TABLE 89 MIDDLE EAST: ONYCHOMYCOSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 92

TABLE 90 MIDDLE EAST: ONYCHOMYCOSIS MARKET, BY TREATMENT TYPE, 2023–2030 (USD MILLION) 93

TABLE 91 MIDDLE EAST: ONYCHOMYCOSIS MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION) 93

TABLE 92 AFRICA: ONYCHOMYCOSIS MARKET, BY TYPE, 2023–2030 (USD MILLION) 94

TABLE 93 AFRICA: ONYCHOMYCOSIS MARKET, BY TREATMENT TYPE, 2023–2030 (USD MILLION) 94

TABLE 94 AFRICA: ONYCHOMYCOSIS MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION) 95

TABLE 95 GLOBAL ONYCHOMYCOSIS MARKET: COMPANY SHARE ANALYSIS, 2023 (%) 96

14 List Of Figures

FIGURE 1 MARKET SYNOPSIS 15

FIGURE 2 MARKET ATTRACTIVENESS ANALYSIS: GLOBAL ONYCHOMYCOSIS MARKET 16

FIGURE 3 GLOBAL ONYCHOMYCOSIS MARKET SHARE, BY TYPE, 2023 (%) 16

FIGURE 4 GLOBAL ONYCHOMYCOSIS MARKET, BY TYPE, 2017–2030 (USD MILLION) 17

FIGURE 5 GLOBAL ONYCHOMYCOSIS MARKET SHARE, BY TREATMENT TYPE, 2023 (%) 17

FIGURE 6 GLOBAL ONYCHOMYCOSIS MARKET, BY TREATMENT TYPE, 2017–2030 (USD MILLION) 17

FIGURE 7 GLOBAL ONYCHOMYCOSIS MARKET SHARE, BY DISTRIBUTION CHANNEL, 2023 (%) 18

FIGURE 8 GLOBAL ONYCHOMYCOSIS MARKET, BY DISTRIBUTION CHANNEL, 2017–2030 (USD MILLION) 18

FIGURE 9 GLOBAL ONYCHOMYCOSIS MARKET: MARKET STRUCTURE 20

FIGURE 10 PRIMARY RESPONDENT’S BREAKDOWN 24

FIGURE 11 BOTTOM-UP AND TOP-DOWN APPROACH 27

FIGURE 12 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL ONYCHOMYCOSIS MARKET 30

FIGURE 13 PORTER’S FIVE FORCES ANALYSIS: GLOBAL ONYCHOMYCOSIS MARKET 34

FIGURE 14 VALUE CHAIN ANALYSIS OF THE GLOBAL ONYCHOMYCOSISMARKET 36

FIGURE 15 GLOBAL ONYCHOMYCOSIS MARKET SHARE, BY TYPE, 2023 (%) 38

FIGURE 16 GLOBAL ONYCHOMYCOSIS MARKET, BY TYPE, 2023 AND 2030 (USD MILLION) 39

FIGURE 17 GLOBAL ONYCHOMYCOSIS MARKET SHARE, BY TREATMENT TYPE, 2023 (%) 44

FIGURE 18 GLOBAL ONYCHOMYCOSIS MARKET, BY TREATMENT TYPE, 2023 AND 2030 (USD MILLION) 44

FIGURE 19 GLOBAL ONYCHOMYCOSIS MARKET SHARE, BY DISTRIBUTION CHANNEL, 2023 (%) 47

FIGURE 20 GLOBAL ONYCHOMYCOSIS MARKET, BY DISTRIBUTION CHANNEL, 2023 AND 2030 (USD MILLION) 47

FIGURE 21 GLOBAL ONYCHOMYCOSIS MARKET SHARE, BY REGION, 2023 (%) 50

FIGURE 22 GLOBAL ONYCHOMYCOSIS MARKET, BY REGION, 2023 AND 2030 (USD MILLION) 51

FIGURE 23 AMERICAS: ONYCHOMYCOSIS MARKET, BY REGION, 2023 AND 2030 52

FIGURE 24 NORTH AMERICA: ONYCHOMYCOSIS MARKET, BY COUNTRY, 2023 AND 2030 55

FIGURE 25 ASIA-PACIFIC: ONYCHOMYCOSIS MARKET, BY COUNTRY, 2023 AND 2030 62

FIGURE 26 EUROPE: ONYCHOMYCOSIS MARKET, BY REGION, 2023 AND 2030 74

FIGURE 27 WESTERN EUROPE: ONYCHOMYCOSIS MARKET, BY COUNTRY, 2023 AND 2030 77